A new study finds that menopausal hormone therapy formulation significantly impacts autoimmune disease risk, with estrogen-only therapy associated with higher hazards for conditions like lupus and rheumatoid arthritis. The study suggests that progestogen may limit these risks, warranting further investigation.
A new study found that nearly 100 male partners of women experiencing menopause were unprepared to support their partners, with 68% knowing little or nothing about menopause before their partner's transition. The study identified four dominant themes: loss of intimacy, emotional distress, and lack of male-focused education and support ...
A new study finds that hormone therapy is associated with significantly greater and sustained weight loss with GLP-1 medications, particularly semaglutide, in midlife women. However, the effect was weaker with tirzepatide, and more research is needed to confirm these findings.
A new study found that excessive bloating and gas were the most prevalent gastrointestinal symptoms during all three phases of menopause, with anxiety being the worst during perimenopause. Researchers confirmed that GI symptom severity did not differ significantly by menopause stage, but anxiety scores were highest during perimenopause.
A new study has found a significant association between testosterone therapy and an increased risk of incident cardiovascular disease in postmenopausal women. The study, which included over 6,300 women, found that testosterone therapy was associated with a 3.8% vs 0.5% hazard ratio for composite cardiovascular disease outcomes.
A new review suggests that ADHD medications can significantly improve self-reported executive function during the menopause transition, with stimulant and non-stimulant medications showing promise. However, the impact on objective cognitive measures, such as working memory and sustained attention, was limited. The findings could lead t...
A pilot study found that microablative fractional radiofrequency may increase vaginal epithelial thickness and stromal collagen fiber size in postmenopausal women with genitourinary syndrome of menopause, although results were not statistically significant.
A new study suggests that combining estrogen and testosterone therapy may improve bone mineral density in postmenopausal women, particularly at the lumbar spine. The research found that testosterone therapy exerted a synergistic effect with estrogen, leading to increased bone mineral density.
A new study found premature menopause to be associated with higher insulin levels and greater cardiovascular disease risk. Insulin resistance was found to be a possible connection between premature menopause and cardiovascular disease, highlighting the importance of cardiometabolic health in women who experience menopause before age 40.
A new study suggests that psychological symptoms of menopause, rather than physical symptoms, are the primary drivers of increased turnover among perimenopausal and postmenopausal employees. Menopause-specific psychological symptoms, such as those measured by the Menopause Rating Scale, were found to have a strong association with turn...
A new study found that vaginal estrogen use is associated with a higher risk of perioperative UTIs in postmenopausal women experiencing hip fractures. Women with a history of recurrent UTIs were more likely to report perioperative vaginal estrogen use and experience a UTI.
A new study suggests that hormone therapy is associated with a greater migraine burden in postmenopausal women, with increased frequency and duration of migraine attacks, but no significant impact on symptom intensity or treatment needs. The study, which analyzed data from nearly 24,000 women, provides new insights into the relationshi...
A new study of over 1,800 women from 87 countries found that regular physical activity is associated with lower symptom burden in perimenopause, particularly psychological symptoms like low mood and anxiety. The study suggests that physical activity may be a low-risk strategy to improve overall well-being during the menopause transition.
Continuous transdermal nitroglycerin may reduce hot flash frequency in postmenopausal women who cannot use hormone therapy, with modest and inconsistent evidence. The treatment shows potential as a nonhormone option, but larger trials are needed to confirm its efficacy and safety.
Neurokinin receptor antagonists may affect molecular pathways involved in breast cancer growth and invasiveness, limiting cancer cell spread and preventing recurrence. Laboratory and tissue-based studies found NKB receptors over-expressed in cancerous breast tissue, reducing cancer cell viability and downregulating oncogenic pathways.
A new study presents an AI-enhanced virtual reality program, MenoZen VRTM, that effectively delivers cognitive behavioral therapy to manage menopause symptoms. The program addresses access barriers to traditional therapies, providing a personalized and convenient solution for midlife women.
A new study reveals significant gaps in menopause education among US family physicians, despite the growing need for standardized training. The study found that most programs have dedicated menopause curricula or integrated women's health education, but lack formal assessments to ensure consistency and depth of training.
Dr. Jill Biden will join Dr. Stephanie Faubion to discuss bridging gaps in women's health research, education, and care at The Menopause Society's 2026 Annual Meeting. The event aims to close longstanding gaps in women's health, highlighting the importance of innovation and collaboration.
A new study found that hormone therapy improved mood symptoms in midlife women, with significant reductions in severe mood disturbances. The treatment benefited those with elevated baseline severity, regardless of prior mental health diagnosis or medication use.
A scoping review highlights the inconsistencies in documenting menopause symptoms and status in EHR systems, leading to gaps in quality clinical treatment, research, and positive health outcomes for midlife women. Standardized menopause data elements are crucial to advancing menopause care.
A new study found that social disadvantage significantly amplifies adverse health trajectories in women with early natural menopause. Unemployment was strongly associated with increased risk of all-cause mortality and incident dementia, emphasizing the need for comprehensive assessments of social determinants of health.
A new study found that women with type 2 diabetes are at higher risk of experiencing severe menopause symptoms. The study, published in Menopause journal, analyzed data from nearly 300 women and discovered a significant association between diabetes and increased prevalence and severity of menopause symptoms across all stages.
Women who experience premature menopause are at a higher risk of developing high blood pressure, with the risk peaking among those who reach menopause between ages 25 and 35. The study suggests that clinicians should consider age at menopause as a distinct cardiovascular risk factor for women who reach menopause before age 40.
A new large-scale study estimates that roughly one-third of women experience perimenopause uncertainty, which is prevalent due to knowledge gaps, symptom confusion, and healthcare barriers. The study found that younger women are more likely to cite knowledge gaps, while older women face greater challenges with accessing care.
A new study compared menopause symptoms in women at the average age of 51 years and those with premature ovarian insufficiency, finding similar symptom burden in psychological and urogenital domains. Urogenital symptoms, including sexual problems and bladder issues, were the most commonly reported in both groups.
A new study of over 10,000 women reveals that those taking hormone therapy are more likely to engage in healthy behaviors such as a balanced diet and regular physical activity. Meanwhile, postmenopausal women who never used hormone therapy reported shorter sleep durations.
A new study found that surgical menopause causes more severe genitourinary syndrome of menopause phenotype, with increased symptoms and exam findings compared to natural menopause. This may lead to a higher risk of vaginal dryness, pain during intercourse, urination, reduced sexual desire, and postcoital bleeding.
The Menopause Society is expanding its education and outreach efforts with a new $10 million grant from Pivotal, providing training for healthcare professionals and targeting areas with low access to menopause care. The grant will help improve women's health during the menopause transition and beyond.
A new study found that women with primary infertility have an increased risk of early menopause and collectively underwent menopause 1 year earlier. Women with unexplained infertility or endometriosis were particularly at risk for early menopause, highlighting the need for counseling and evaluation.
A new study suggests that postmenopausal women with low femoral bone mineral density are at a higher risk of death, with a 47% increased risk compared to those with normal bone density. The study, published in Menopause, also reveals an inverse relationship between bone mineral density and mortality risk within specific ranges.
A new study suggests that abdominal obesity can lead to a higher prevalence and greater severity of menopause symptoms, including dizziness, hot flashes, and night sweats. Women with abdominal obesity exhibit distinct symptom network structures, highlighting the importance of targeted interventions.
A new study suggests that cognitive-behavioral therapy intervention can produce meaningful short-term improvements in insomnia severity, hot flash interference, sleep self-efficacy, and depressive symptoms. The therapy demonstrated a feasible and promising approach to address menopause-related insomnia and nocturnal hot flashes.
A new large-scale study of over 14,000 women found that those with a longer reproductive span experienced better cognitive health, while hormone therapy use within 10 years of menopause showed no significant benefits. The results support current guidelines against hormone therapy for preventing dementia.
A new study found that targeted, case-based learning improved provider confidence and identified critical unmet educational needs in menopause care. Clinicians reported high satisfaction with the program and noted anticipated changes in clinical practice, such as increased comfort initiating treatment.
A new study found that loneliness and social isolation are independently and jointly associated with subjective cognitive decline in perimenopausal women. The study, published in Menopause, suggests that promoting healthy social connections may help mitigate cognitive deterioration during this time.
A new study has demonstrated the safety of short-term vaginal estrogen therapy in younger survivors of endometrial cancer. The research shows that local, low-dose vaginal estrogen does not increase a woman's risk of cancer recurrence, providing hope for women who have experienced this type of cancer.
A new study suggests that nonablative capacitive-resistive monopolar radiofrequency (CRMRF) may improve vaginal health and sexual function in postmenopausal women. The treatment achieved significant improvements in overall sexual function, particularly in lubrication, orgasm, and pain.
A new study found that hormone therapy after age 65 remains risky, but effective for some women, emphasizing the need for personalized risk assessments and monitoring. Women aged 65+ were more likely to experience health issues like cancer, cardiovascular events, and osteoporosis with hormone therapy.
A new study based on data from over 17,000 women across 158 countries found inconsistent knowledge of perimenopause symptoms and actual experiences. Commonly recognized symptoms included hot flashes, sleep problems, and weight gain, but women most reported experiencing fatigue, physical and mental exhaustion, and irritability.
A new study found that hormone therapy is significantly underused in women with premature ovarian insufficiency (POI), a condition characterized by early menopause. Only 36% of women with POI received hormone therapy, highlighting the need for education and training to improve care.
A large-scale study of nearly 147,000 women found that early or premature menopause is not associated with an increased risk of type 2 diabetes. Despite increased fat and insulin resistance during menopause, the study found no independent relationship between age or type of menopause and the onset of diabetes.
A new study of over 3,000 women aged 60+ found that using sex toys during masturbation leads to a higher frequency of orgasm. The study suggests that older women could benefit from receiving more information on sex toy use and orgasm promotion from healthcare professionals.
A new study published in Menopause highlights the association between sleep-related disorders and increased risk of hypertension in postmenopausal women. The study found that both insufficient and excessive sleep were associated with an increased risk of hypertension, highlighting the importance of improving sleep quality and optimal w...
A new study found that central adiposity, measured by waist-to-hip ratio, is a risk factor for domain-specific cognitive decline in postmenopausal women. The study suggests that measures of central adiposity may serve as early and easily recognizable markers of risk for both metabolic and cognitive dysfunction.
A $5 million grant from the Steven & Alexandra Cohen Foundation will support The Menopause Society's NextGen Now initiative, creating a comprehensive digital ecosystem for menopause education and training worldwide. The initiative aims to improve healthcare professionals' care for midlife women and enhance their knowledge of menopause.
A systematic review suggests that hormone therapy may help alleviate anxiety symptoms in midlife women, particularly those taking oral estrogen, but with varying degrees of benefit. The study's findings have implications for clinicians in individualizing treatment plans for patients with menopause-related anxiety.
A new study suggests that women with earlier menopause are more susceptible to memory decline due to genetic predispositions like the APOE e4 gene. Higher levels of inflammation exacerbate this effect, particularly in APOE e4 carriers.
A large-scale analysis found that women who started hormone therapy during perimenopause had a 60% lower risk of developing breast cancer, heart attack, and stroke compared to those who did not. The study's findings highlight the potential benefits of initiating estrogen therapy earlier in menopause
A new study finds that earlier menopause can negatively influence the associations between cardiac function and gray matter volume, white matter hyperintensity burden, and cognitive performance. Reduced cardiac function can also damage brain tissue and increase dementia risk by limiting oxygen and nutrient supply.
A new large-scale study found that women who experience early natural menopause have a significantly higher risk of developing metabolic syndrome compared to those with later menopause. The study, which analyzed data from over 234,000 women, revealed an increased relative risk of 27% for women experiencing early menopause.